Navigation Links
Advanced Life Sciences Announces US Army Collaboration to Research and Develop Restanza for the Treatment of Malaria
Date:11/2/2010

CHICAGO, Nov. 2, 2010 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that it has entered into a Cooperative Research and Development Agreement ("CRADA") with The Walter Reed Army Institute of Research.  The purpose of this CRADA is to allow The Walter Reed Army Institute of Research to perform advanced animal efficacy testing of Restanza™ (cethromycin), the Company's novel oral antibiotic, against various Plasmodium species that cause malaria.  This CRADA is built on the positive in vitro and in vivo efficacy results that Restanza demonstrated in initial studies with Walter Reed.

(Logo:  http://photos.prnewswire.com/prnh/20080218/ALSLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

"Developing new treatments for malaria is a high-priority for the US military because of malaria's global prevalence, debilitating nature, potential lethality, and tendency to become resistant to current drugs," stated Michael T. Flavin, Ph.D., chief executive officer of Advanced Life Sciences.  "We share the US Army's mission to protecting our troops in the field with novel therapies that can combat infectious diseases such as malaria.  Advanced Life Sciences remains committed to developing Restanza as a new drug to protect public health and we are very pleased to expand our collaboration with the Walter Reed Army Institute of Research toward this goal."

In May 2010, the Company announced that preliminary in vitro and i
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Clinicians Use Advanced Radiotherapy Imaging Techniques from Elekta to More Accurately Visualize Moving Tumors in Patients with Lung Cancer
2. Advanced Targeting Systems, Inc. Announces $3 Million Award from National Cancer Institute
3. Aeterna Zentaris Announces NIH Grant for a Phase 1/2 Study in Advanced Prostate Cancer with AEZS-108
4. Elusys Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax
5. Advanced Life Sciences Expands Antibiotic Pipeline
6. Advanced Life Sciences CEO Acquires $2 Million of Common Stock Through Debt for Equity Exchange
7. Reportlinker Adds Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
8. Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
9. Sermo Announces New Client Center with Advanced Mining and Monitoring of Organic Physician Dialog
10. Advanced Life Sciences Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use
11. Advanced Phase I and Phase II Studies of Targeted Gene Delivery Confirm That Rexin-G Impacts Survival in Chemotherapy-resistant Bone and Soft Tissue Sarcoma (ASCO 2010)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine and Professor ... Einstein College of Medicine and Associate Chairman of the ... He is also Associate Director for Clinical Research at ... Cancer Working Group, a multidisciplinary group of physicians and ... serves as Vice Chair of the National Cancer Institute ...
(Date:5/17/2013)... occurs when the transplant recipient,s immune system identifies the ... was previously thought that T cells, the immune cells ... known as chemokines in order to migrate to the ... of Clinical Investigation , Fadi Lakkis and colleagues at ... chemokine stimulation of T cells is not required for ...
(Date:5/17/2013)... a world-leading provider of scientific, technical and medical information ... recent study in Reproductive BioMedicine Online ... with an abnormal chromosomal composition can be identified by ... thereby classifying the risk of genetic abnormality without a ... undertaken a retrospective study, using their predictive model to ...
(Date:5/17/2013)... 2013 •    First of its kind research ... ,     New facility will help solve crop stresses ... Syngenta unveiled its new crop research facility during ... Innovation Center. The first of its kind, $72 million ... agricultural climate and precisely measure plant inputs – the ...
Breaking Biology Technology:Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3
... part of its ongoing mission to provide comprehensive ... clinical trials, Clinical Financial Services (CFS) is pleased ... Site Activation Services. This revolutionary new service, which ... as global investigator budget and contract management, will ...
... -- China Botanic Pharmaceutical Inc. (NYSE AMEX: ... a developer, manufacturer and distributor of botanical products, ... today announced that the Company successfully showcased its ... fair") recently held in Chengdu, China. ...
... DIEGO, May 17, 2011 Verenium Corporation (Nasdaq: ... on the development and commercialization of high-performance enzymes, today ... MDB Capital Group at the second annual Bright Lights ... Bright Lights Conference is the only conference with an ...
Cached Biology Technology:Clinical Financial Services (CFS) Launches New Service to Streamline Clinical Trial Activation 2China Botanic Exhibits All-Natural Products at the 65th PHARMACHINA Fair 2China Botanic Exhibits All-Natural Products at the 65th PHARMACHINA Fair 3Verenium Receives CLARUS Award at MDB Capital's Bright Lights Conference 2011 2Verenium Receives CLARUS Award at MDB Capital's Bright Lights Conference 2011 3Verenium Receives CLARUS Award at MDB Capital's Bright Lights Conference 2011 4
(Date:5/16/2013)... neuroscientists from Canada and around the world are ... Canadian Neuroscience Meeting will showcase the latest in ... and reveal clues to understanding the disorders that ... research, and this meeting will showcase the best ... world," says Sam David, President of the Canadian ...
(Date:5/16/2013)... outside of the gym. But doctors use the human pulse ... Bao, a professor of chemical engineering at Stanford, has developed ... wider than a postage stamp. The flexible skin-like monitor, worn ... to help doctors detect stiff arteries and cardiovascular problems. , ... heart health and provide doctors a safer method of measuring ...
(Date:5/16/2013)... HAMBURG, Germany , May 16, 2013 ... Customer Value Enhancement Award on Tuesday to ... for its exceptional biometric border control system. ... Sullivan with the Best Practices Award in the category ...  for its cutting edge Biometric   Border Control ...
Breaking Biology News(10 mins):7th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4
... researchers will use grants of state money to develop ... can detect food contamination, design taller wind turbine towers ... the state,s economy. The state Board of Regents ... grants totaling $942,389 from Iowa State,s $1.459 million share ...
... productivity that once was on the rise with warming temperatures ... because of regional drought according to a new study of ... of the rate of the photosynthesis process that green plants ... sugar, oxygen and eventually plant tissue. Compared with a 6 ...
... This release is available in German . ... are packaged in a highly characteristic fashion. Most of the ... are connected to each other by flexible DNA segments, like ... in deciding which genes are actively expressed, and thus which ...
Cached Biology News:Iowa State awards grants to develop health, energy and research technologies 2Iowa State awards grants to develop health, energy and research technologies 3Iowa State awards grants to develop health, energy and research technologies 4Drought drives decade-long decline in plant growth 2Road signs and traffic signals on DNA 2Road signs and traffic signals on DNA 3
... Application: Useful for the determination of digitonin ... sucrose, 0.4% EDTA Na 4 and 0.06% ... Nakao, et al., Biochem. Biophys. Res. Commun., ... liberate 1.0 mole of inorganic phosphorus from ATP ...
... 3C protease from human rhinovirus (HRV 3C) ... brand line of restriction grade proteases. The ... 6XHis-fusion protein, which recognizes the same cleavage ... small, 22 KDa size of the protease, ...
... series is designed to enhance your ... applications at a reasonable cost. ... connect rotors and various biocontainment options. ... allows you to control and view ...
p230 trans Golgi Purified Anti-Human clone 15, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
Biology Products: